Silk Road Medical (SILK) reported Tuesday its Q2 loss widened to $0.44 per share from $0.31 a year ago. Analysts polled by Capital IQ expected a loss of...
...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Silk Road Medical (SILK) shares shed more than 4% in Monday afternoon trading after Citigroup downgraded the stock to sell from neutral. Trading volume...
| Address | 1213 Innsbruck Drive Sunnyvale, California 94089 |
| Phone | +1.408.720.9002 |
| Number of Employees | 176 |
| Recent SEC Filing | 08/12/2022 4 |
| President, Chief Executive Officer & Director | Erica J. Rogers |
| Chief Financial & Operating Officer | Lucas W. Buchanan |
| Executive Medical Director | Sumaira Macdonald |
| VP-Professional Education & Medical Affairs | Tammy Leitsinger |
| Price Open | $48.60 |
| Previous Close | $48.38 |
| 52 Week Range | $27.21 - 67.49 |
| Market Capitalization | $1.7 B |
| Shares Outstanding | 35.2 M |
| Sector | Health Technology |
| Industry | Medical Specialties | Next Earnings Announcement | 11/08/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$1.73 |
| Beta vs. S&P 500 | N/A |
| Revenue | $34.6 M |
| Net Profit Margin | -53.13% |
| Return on Equity | -82.20% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
